<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>33</volume>
<number>159</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Prognostic Value of Circular RNAs in Digestive System Malignancies: Evidence From a Systematic Review and Meta-analysis</title>
	<subject_fa>Medical Biology</subject_fa>
	<subject>Medical Biology</subject>
	<content_type_fa>مقاله مروری</content_type_fa>
	<content_type>Review Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Dysregulation of circular RNAs (circRNAs) has been implicated in the development and progression of various cancers. However, their clinicopathological and prognostic value in digestive system malignancies remains unclear. This meta-analysis was performed to investigate the potential prognostic role of circRNAs in these cancers, classifying them as oncogenic or tumor-suppressor based on original study findings, while noting context-dependent roles. A comprehensive electronic literature search was conducted to identify eligible studies evaluating the prognostic significance of circRNAs in digestive cancers. Pooled hazard ratios (HRs), odds ratios (ORs), and 95% confidence intervals (CIs) were calculated to assess the associations between circRNA expression and overall survival (OS), as well as clinicopathological parameters. A total of 111 eligible studies were included in this meta-analysis. High expression of oncogenic circRNAs was significantly associated with worse OS (HR = 1.90, 96% CI: 1.72&amp;ndash;2.22; P &lt; 0.001), while elevated tumor-suppressor circRNAs showed a non-significant protective trend (HR = 0.74, 95% CI: 0.54&amp;ndash;1.03; P &gt; 0.05). Upregulated circRNAs were also significantly correlated with advanced TNM stage (OR = 2.68, 95% CI: 2.09&amp;ndash;3.45) and larger tumor size (OR = 1.52, 95% CI: 1.16&amp;ndash;1.98). Conversely, downregulated circRNAs showed&amp;nbsp;an inverse association with advanced TNM stage (OR = 0.44, 95% CI: 0.25&amp;ndash;0.79) and tumor size (OR = 0.51, 95% CI: 0.34&amp;ndash;0.77). High heterogeneity (I&amp;sup2; &gt; 50%) was observed, likely due to diverse cancer types and detection methods, but sensitivity analyses confirmed the result robustness. Egger&amp;rsquo;s test indicated potential publication bias (P &lt; 0.05). Mechanistically, circRNAs influence prognosis via miRNA sponging, RNA-binding protein interactions, and transcriptional regulation. This meta-analysis provides robust evidence that aberrant circRNA expression is associated with aggressive tumor characteristics and poor prognosis in digestive system cancers. However, clinical translation is limited by non-standardized detection methods and reliance on tissue-based assays. Large-scale, multicenter studies with standardized detection protocols and liquid biopsy validation are required to establish circRNAs as non-invasive prognostic biomarkers.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Circular RNA, Digestive System Neoplasms, Meta-analysis, Prognosis, Biomarkers</keyword>
	<start_page>249</start_page>
	<end_page>264</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-7215-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Shams</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shams8869@yahoo.com</email>
	<code>5200319475328460085794</code>
	<orcid>5200319475328460085794</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad-Hassan</first_name>
	<middle_name></middle_name>
	<last_name>Arjmand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>arjmndmh@mums.ac.ir</email>
	<code>5200319475328460085795</code>
	<orcid>5200319475328460085795</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Transplant Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Elnaz</first_name>
	<middle_name></middle_name>
	<last_name>Zahiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zahirie2@mums.ac.ir</email>
	<code>5200319475328460085796</code>
	<orcid>5200319475328460085796</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hassan</first_name>
	<middle_name></middle_name>
	<last_name>Mehrad-Majd</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mehradmajdh@mums.ac.ir</email>
	<code>5200319475328460085797</code>
	<orcid>5200319475328460085797</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
